PG
MLAB icon

Pendal Group’s Mesa Laboratories MLAB Stock Holding History

Pendal Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,041
Closed -$902K – 481
2017
Q3 		$902K Buy
6,041
+4,109
+213% +$580K 0.01% 323
2017
Q2 		$277K Buy
+1,932
New +$275K ﹤0.01% 410

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Pendal Group's MLAB Position: Q4 2017 in Review

Pendal Group sold out of Mesa Laboratories (MLAB) in Q4 2017, closing a stake of 6,041 shares — an estimated $902K sold.

Pendal Group first reported a position in MLAB in Q2 2017 and held it in 2 quarters. The position peaked at $902K in Q3 2017. 93 funds tracked by Wall St. Rank hold MLAB as of Q4 2017.

  • Pendal Group reported no remaining Mesa Laboratories position as of Q4 2017 after selling out during the quarter.
  • Pendal Group sold 6,041 Mesa Laboratories shares in Q4 2017, an estimated $902K.
  • Pendal Group first reported a position in Mesa Laboratories in Q2 2017 and held it in 2 quarters.
  • Pendal Group's Mesa Laboratories position peaked at $902K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2017.

Based on Pendal Group's 13F filing for Q4 2017, filed 6 Feb 2018.